No black box warning on record for Ashlyna

As of the latest FDA labeling reviewed, Ashlyna (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ashlyna medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Vascular risks: Stop if a thrombotic or thromboembolic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years. ( 5.1 ) • Liver disease: Discontinue if jaund

No black box warning on record for Ashlyna

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Vascular risks: Stop if a thrombotic or thromboembolic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years. ( 5.1 ) • Liver disease: Discontinue if jaund

Ashlyna Black Box Warning

No black box warning on record for Ashlyna

Other warnings & precautions

Ashlyna Black Box Warning

No black box warning on record for Ashlyna

Other warnings & precautions